The current global food system “simply isn’t sustainable.” That’s the stark warning from Jeremy Coller, a leading investor in alternative proteins, delivered to global investors attending ‘FoodTech on the Frontline: Invest in the Startups Feeding the Future,’ an online event hosted by OurCrowd and the Fresh Start FoodTech Incubator in Kiryat Shmona. Read...
Read MoreNEW YORK, Oct. 12, 2023 /PRNewswire/ — Madison Square Garden Sports Corp. (NYSE: MSGS) (“MSG Sports”) and Madison Square Garden Entertainment Corp. (NYSE: MSGE) (“MSG Entertainment”) announced today a new partnership with Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, naming the brand the first-ever Official Plant-Based Meat Partner of Madison Square Garden, New York Knicks, Knicks Gaming (NBA 2K League), New York Rangers, and the Arena Concert Series at Madison Square Garden. Read...
Read MoreTEL AVIV, Israel, Nov. 20, 2023 /PRNewswire/ — Arbe Robotics Ltd. (NASDAQ: ARBE), a global leader in Perception Radar Solutions, announced today that Cars of the Future awarded the company the Self-Driving Industry 2023 Award in the hardware category. Read more...
Read MoreJERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K. (“HekaBio”) a Japan-based healthcare investment, development and commercialization platform which is partnered with Alpha Tau, announced today that Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer, following multiple pre-submission consultation meetings with the PMDA per common practice in Japan. This submission is based upon Alpha DaRT’s clinical trial results in Japan which exceeded the target endpoints for safety and efficacy in patients with recurrent head and neck cancer. Read...
Read MoreTEL AVIV, Israel and NEW YORK, Nov. 20, 2023 /PRNewswire/ — BioCatch, the global leader in digital fraud and money laundering detection and response powered by behavioral biometric intelligence, today announced that it has reached Centaur status, surpassing $100m in annual recurring revenue. Read...
Read More
